Volume 34 Issue 5
Sep.  2018
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2018  >  34(5): 448-451
MIAO Xiao-fan, WANG Fang, LIN Xin. Clinical Study on Prevention and Treatment of Contrast-Induced Nephropathy with Baoshen Tablets in Perioperative Period of Coronary Intervention[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(5): 448-451.
Citation: MIAO Xiao-fan, WANG Fang, LIN Xin. Clinical Study on Prevention and Treatment of Contrast-Induced Nephropathy with Baoshen Tablets in Perioperative Period of Coronary Intervention[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(5): 448-451.
shu

Clinical Study on Prevention and Treatment of Contrast-Induced Nephropathy with Baoshen Tablets in Perioperative Period of Coronary Intervention

  • Received Date: 2018-05-19
  • Publish Date: 2018-09-10
    Abstract
  • OBJECTIVE To observe the effect and mechanism of Baoshen Tablets in preventing contrast-induced nephropathy after coronary intervention. METHODS 80 patients with coronary intervention were randomly divided into experimental group and control group. The control group was treated with standard basic treatment of coronary disease. The experimental group was given Baoshen Tablets， 4 tablets/time， 3 times a day on the basis of the control group. The serum creatinine (Scr)， urea nitrogen (BUN)， cystatin C (CysC)， glomerular filtration (eGFR)， urinary N-acetyl β-glucosaminidase (NAG) and urinary β-galactosidase level (GAL) levels were observed before surgery， 24 h and 72 h after surgery. RESULTS The comparison of the two groups in the same time showed that there was no significant difference in the levels of kidney injury markers before operation. After 24 h of operation， the level of CysC in experimental group was lower than that in control group (P<0.05). After 72 h of operation， the Scr， BUN， CysC， NAG， GAL in experimental group were lower than those in control group， while eGFR in experimental group was significantly higher than that in control group (P<0.05). The comparison of the same group in different time showed that CysC in control group after 24 h of operation was higher than the preoperative level (P<0.05). After 72 h of operation， the level of Scr， BUN， NAG， GAL were lower than the preoperative level (P<0.05)，while eGFR was higher than the preoperative leve in experimental group (P<0.05). In control group， after 72 h of operation， the levels of Scr， BUN， CysC， NAG and GAL were higher than the preoperative level (P<0.05)， and eGFR was lower than the preoperative level (P<0.05). CONCLUSION Baoshen Tablets can prevent and treat contrast-induced nephropathy for patients with the perioperative period of coronary intervention.

     

    • FullText(HTML)
  • loading
    • References(11)
  • [1]
    REAR R， BELL RM， HAUSENLOY DJ. Contrast-induced nephropathy following angiography and cardiac interventions[J]. Heart， 2016， 102(8):638-648.
    [2]
    LAMEIRE N， KELLUM JA. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary[J]. Crit Care， 2013， 17(1): 205-217.
    [3]
    韩雅玲.2016年中国经皮冠状动脉介入治疗指南[J].中华心血管病杂志，2016，44(5):382-400.
    [4]
    JAMES MT， SAMUEL SM， MANNING MA， et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis[J]. Circ Cardiovasc Interv， 2013， 6(1): 37-43.
    [5]
    MCDONALD JS， MCDONALD RJ， COMIN J， et al. Frequency of acute kidney injury following intravenous contrast medium administration: A systematic review and meta-analysis[J]. Radiology， 2013， 267(1): 119-128.
    [6]
    AURELIO A， DURANTE A. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis， risk factors， outcome， prevention and treatment[J]. Cardiology， 2014， 128(1): 62-72.
    [7]
    KIESSLING AH，DIETZ J，REYHER C，et al. Early postoperative serum cystatin C predicts severe acute kidney injury following cardiac surgery: A post-hoc analysis of a randomized controlled trial[J]. J Cardiothorac Surg， 2014， 9(1): 10-16.
    [8]
    YOUSEFZADEH G， PEZESHKI S， GHOLAMHOSSEINIAN A， et al. Plasma cystatin-C and risk of developing gestational diabetes mellitus[J]. Diabetes Metab Syndr， 2014， 8(1):33-35.
    [9]
    ZHANG GX， WANG XF， ZHANG P， et al. The clinical study of the Shenhuangcao-mixture treating early renal injury[J]. Chin J Inf TCM，2002，9(12): 16-17．
    [10]
    陈鹏， 牛琳琳， 朱明军， 等. 中药对冠脉介入术后造影剂肾病防治的作用机制浅析[J]. 中国中西医结合杂志， 2016， 36(8): 991-993.
    [11]
    柳于介， 马芳玉， 王亿平， 等. 保肾片治疗慢性肾功能衰竭气阴两虚兼湿浊证临床观察[J]. 中国实验方剂学杂志， 2011， 17(10):259-262.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2608) PDF downloads(1771) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return